Cite
Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage.
MLA
Thabard, W., et al. “Myeloma Cells Release Soluble Interleukin-6Ralpha in Relation to Disease Progression by Two Distinct Mechanisms: Alternative Splicing and Proteolytic Cleavage.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 5, no. 10, Oct. 1999, pp. 2693–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10537331&authtype=sso&custid=ns315887.
APA
Thabard, W., Barillé, S., Collette, M., Harousseau, J. L., Rapp, M. J., Bataille, R., & Amiot, M. (1999). Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 5(10), 2693–2697.
Chicago
Thabard, W, S Barillé, M Collette, J L Harousseau, M J Rapp, R Bataille, and M Amiot. 1999. “Myeloma Cells Release Soluble Interleukin-6Ralpha in Relation to Disease Progression by Two Distinct Mechanisms: Alternative Splicing and Proteolytic Cleavage.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 5 (10): 2693–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10537331&authtype=sso&custid=ns315887.